# Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial

> **NCT05293106** · PHASE4 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 9 (actual)

## Conditions studied

- Cardiopulmonary Bypass Surgery

## Interventions

- **BIOLOGICAL:** Platelet Transfusion

## Key facts

- **NCT ID:** NCT05293106
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-07-05
- **Primary completion:** 2023-09-17
- **Final completion:** 2023-09-27
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Difficulty recruiting and enrolling subjects.
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05293106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05293106, "Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05293106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*